FDA Inspection
Mayo Clinic Health System MankatoMayo Clinic Health System Mankato – FDA Inspection, Jan 28, 2026
Record Details
This FDA Inspection record concerns Mayo Clinic Health System Mankato, with an inspection on January 28, 2026, issued by the Minneapolis District Office, covering biologics.
View Company Profile
ID · fa7367b7-c3b5-4f14-aff6-366ca6601b4c
Inspection Facts
- Inspection number
- 1304402
- FDA center
- Biologics
Other FDA inspections of Mayo Clinic Health System Mankato
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 11, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 22, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 16, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Mayo Clinic Health System Mankato
- FDA Inspection 1121192 - 2020-02-11
- FDA Inspection 1057119 - 2018-05-22
- FDA Inspection 982406 - 2016-08-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.